Skip Navigation National Cancer Institute U.S. National Institutes of Health

Fighting HIV/AIDS and HIV Malignancies through...

HIV/AIDS and HIV Malignancy Research in the NCI:

The NCI has played a major role in HIV/AIDS research since the beginning of the epidemic, when a cluster of cases of Kaposiís sarcoma was one of the harbingers of this new disease. NCI scientists have made a number of key discoveries in both HIV/AIDS and AIDS-associated cancer. Today, this research is carried out in multiple Divisions and Offices of the NCI.   |   Learn More

OHAMís Role:

OHAM is responsible for coordinating and overseeing HIV/AIDS research throughout the NCI. In addition, it directly oversees a number of programs in AIDS-related cancer as well as HIV/AIDS.   |   Learn More


New immunotherapy trial for HIV-positive cancer patients

NIH develops new priorities and guidelines to determine AIDS funding beginning in FY 2016. These guidelines will be used to prioritize HIV/AIDS Research projects to determine which are eligible for AIDS-designated funds. Details can be found in NOT-OD-15-137.

Learn more about the new NCI-supported clinical trial, Anal Cancer HSIL Outcomes Research (ANCHOR) Study

   Funding Opportunities View All    News and Events
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers
View All

Save the Date:
16th International Conference on Malignancies in HIV/AIDS (previously called ICMAOI)
October 23-24, 2017
Lister Hill Auditorium, NIH
Bethesda, MD

20TH International Workshop on Kaposi's Sarcoma Herpes Virus (KSHV) and Related Agents
July 25 – 28, 2017
Berlin, Germany

Oral Etoposide Plus Antiretroviral Therapy Study Arm is Discontinued in the AIDS-Kaposi’s Sarcoma Study

CROI 2017: Seattle
February 13-16, 2017
Washington State Convention Center
Seattle, Washington

HPV 2017
February 28 – March 4, 2017
Cape Town, South Africa

NCIís investigators Hughes and colleagues describe a new paradigm in HIV reservoir research